Literature DB >> 32890428

Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy.

Robin Greinert1, Alexander Zipprich1, Macarena Simón-Talero2, Franz Stangl3, Christiane Ludwig1, Andreas Wienke4, Michael Praktiknjo5, Kevin Höhne1, Jonel Trebicka6, Joan Genescà2, Cristina Ripoll1.   

Abstract

AIM: The aim of the study was to evaluate the presence of covert hepatic encephalopathy (cHE) and its characteristics according to the presence of spontaneous portosystemic shunts (SPSS) and their influence on the development of overt hepatic encephalopathy.
METHODS: Secondary analysis of a multicentre study, which evaluated the association between SPSS and complications of cirrhosis. The present study population includes those patients who also underwent cHE diagnostic evaluation. Presence of SPSS was evaluated by cross-sectional imaging and quantified by total SPSS-area. Logistic and Cox-regression competing risk analyses were performed.
RESULTS: About 65 patients were included of age 58 (IQR 50-66), MELD 15 (IQR 10-20), with alcoholic liver disease 63%. Thirty-two patients (49%) had cHE, had higher MELD [16 (IQR 12-24) vs 13 (IQR 9-17), P = .027], a greater proportion of SPSS [n = 18 (56%) vs n = 8 (24%); P = .008] and a higher total cross-sectional SPSS-area [28.3 (0-94.2) vs 0 (0-14.1); P = .005]. On multivariate analysis MELD [OR 1.11 (95% CI 1.01-1.21)] and presence of SPSS [OR 3.95 (95% CI 1.22-12.80)] were independently associated to cHE at baseline. During follow-up cHE was an independent predictor of oHE [cHE: HR 6.93 (95% CI 2.64-18.20). The effect of cHE on the development of oHE was greater in patients with SPSS [only cHE: HR 5.66 (95% CI 1.82-17.62), cHE and SPSS: HR 8.63 (95% CI 3.15-23.65)].
CONCLUSIONS: cHE is independently associated to the presence of SPSS (and total cross-sectional SPSS-area) and MELD. Furthermore, the presence of SPSS seems to increase the risk of cHE of developing of overt hepatic encephalopathy.
© 2020 The Authors. Liver International published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cirrhosis; complications; hepatic encephalopathy; spontaneous portosystemic shunts

Mesh:

Year:  2020        PMID: 32890428     DOI: 10.1111/liv.14660

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  2 in total

1.  Analysis of the Dose-Response Relationship Between the International Normalized Ratio and Hepatic Encephalopathy in Patients With Liver Cirrhosis Using Restricted Cubic Spline Functions.

Authors:  Juntao Tan; Yuxin He; Zhanbiao Li; Qinghua Zhang; Yanzhi Yang; Qian Xu; Xiaomei Xu
Journal:  Front Public Health       Date:  2022-06-28

2.  Long-Term Efficacy and Safety of Rifaximin in Japanese Patients with Hepatic Encephalopathy: A Multicenter Retrospective Study.

Authors:  Hideto Kawaratani; Yasuteru Kondo; Ryoji Tatsumi; Naoto Kawabe; Norikazu Tanabe; Akira Sakamaki; Kazuo Okumoto; Yoshihito Uchida; Kei Endo; Takumi Kawaguchi; Tsunekazu Oikawa; Yoji Ishizu; Shuhei Hige; Taro Takami; Shuji Terai; Yoshiyuki Ueno; Satoshi Mochida; Yasuhiro Takikawa; Takuji Torimura; Tomokazu Matsuura; Masatoshi Ishigami; Kazuhiko Koike; Hitoshi Yoshiji
Journal:  J Clin Med       Date:  2022-03-12       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.